Why Screening Programmes Start At A Particular Age

Screening programmes specify an age at which invitations begin, and the age often looks arbitrary from outside. It is the output of a calculation weighing detection against the costs of testing a whole population.

Screening is offered to people without symptoms

The defining feature of screening is that it tests people who have no reason to think anything is wrong. That distinguishes it entirely from investigating a symptom someone has reported.

Because the tested population is largely healthy, most results will be normal, and every test carries some burden in anxiety, inconvenience and occasionally physical risk.

The programme therefore has to justify imposing that burden on a great many people in order to benefit the smaller number in whom something is found.

Prevalence drives the arithmetic

How useful a positive result is depends heavily on how common the condition is in the group being tested. The same test performs differently in a high-risk and a low-risk population.

In a group where the condition is rare, the majority of positive results will be false, because the small number of true cases is outweighed by the errors generated across everyone else.

Age is used because the risk of most screened conditions rises with it. The starting age marks roughly where prevalence has risen enough for positive results to be informative.

Overdiagnosis is a distinct harm

Some conditions detected by screening would never have caused symptoms during the person's lifetime. Finding them leads to treatment that carries risk without preventing anything.

This is not a false positive, since the finding is real. It is a genuine detection of something that did not need detecting, which is harder to identify and to explain.

Programmes weigh this explicitly, and it is one of the main reasons some proposed screening programmes are not adopted despite the test working as intended.

Intervals reflect how fast disease develops

The gap between invitations is set against how long a condition typically takes to progress from detectable to symptomatic. Faster-developing disease requires shorter intervals.

Conditions that develop slowly can be screened less often without much loss, which reduces the cumulative burden of testing across a lifetime.

Why individual circumstances change the answer

Programme ages describe average risk. Family history, genetic findings and existing conditions can move an individual outside the group the calculation was built for.

That is why people with particular histories are often offered earlier or more frequent testing through a different route than the general programme.

Deciding which applies is a conversation with a doctor, since it depends on details a population-level starting age cannot take into account.